Cost guide · Updated May 2026
Compounded Semaglutide and Tirzepatide Cost in 2026
At-a-glance pricing (2026)
Cash-pay and insurance-billed prices. Pricing verified
| Item | Cost | Note |
|---|---|---|
| Compounded semaglutide (where legal) | $150-$400/mo | |
| Compounded tirzepatide (limited availability) | $200-$450/mo | |
| LillyDirect Self Pay Zepbound (FDA-approved) | $349-$599/mo | |
| NovoCare Self Pay Wegovy (FDA-approved) | $499/mo | |
| Telehealth platform + compounded prescription | $199-$499/mo | includes consult |
What is compounded GLP-1?
Compounded GLP-1 drugs contain the same active ingredients (semaglutide or tirzepatide) as the FDA-approved branded versions (Ozempic, Wegovy, Mounjaro, Zepbound) but are mixed by licensed compounding pharmacies — typically with inactive additives (vitamin B12, glycine) and at non-standard concentrations. Compounded versions are not FDA-approved, not tested in the manufacturer's clinical trials, and not insurance-covered.
Legal compounding in the US occurs through 503A pharmacies (traditional compounding under a physician prescription) and 503B outsourcing facilities (bulk compounding meeting cGMP standards). The 2024 FDA decision to remove semaglutide and tirzepatide from the drug shortage list substantially restricted the legal grounds for compounded GLP-1 production.
Current pricing landscape
Where compounded GLP-1 is still legally available in 2026 (limited clinical scenarios under section 503A), pricing ranges $150-$400/month for semaglutide and $200-$450/month for tirzepatide. This compares to FDA-approved cash-pay programs: LillyDirect Self Pay ($349-$599/month tirzepatide) and NovoCare Self Pay ($499/month Wegovy).
Some telehealth platforms continue to offer compounded GLP-1 prescriptions, but the regulatory landscape is shifting rapidly. Several large compounding pharmacies (Hallandale Pharmacy, ReviveRX) faced FDA warning letters in 2024-2025 citing quality control and legal-status concerns. Patients should verify any compounding pharmacy's current FDA standing before purchase.
Risks of compounded GLP-1
FDA has documented multiple adverse event reports tied to compounded GLP-1 products, primarily dosing errors due to non-standard vial concentrations (compounded semaglutide is often sold at 2.5 mg/mL or 5 mg/mL, vs FDA-approved Ozempic's pre-filled pens with fixed dose markings). Patient confusion between mg and units of measurement has caused 5-10x dosing errors.
Additives like vitamin B12 and glycine added to compounded products have not undergone FDA review for safety, efficacy, or drug interactions during combination with GLP-1 receptor agonists. Some compounded versions use non-pharmaceutical-grade ingredients, raising contamination risk.
Insurance does not cover compounded GLP-1 drugs. If adverse events occur, patients pay out-of-pocket for treatment, and malpractice/liability coverage from the compounding pharmacy varies.
Ways to reduce this treatment cost
- Use manufacturer self-pay programs. LillyDirect (Zepbound/Mounjaro) and NovoCare (Wegovy) sell direct at $349-$599/month — far below retail list price for cash-pay patients.
- Check Cost Plus Drugs and GoodRx for generics. Generic estradiol, progesterone, metformin, and spironolactone run $5-$40/month via Cost Plus Drugs or GoodRx coupons — often 40-60% below pharmacy list.
- Ask about a 90-day supply. Three-month fills usually cost less per month than monthly refills and cut pharmacy trips.
- Appeal insurance denials. Prior-authorization denials for GLP-1 and HRT have ~60-70% reversal rates on appeal with documented BMI/comorbidity history.
- Use HSA/FSA dollars. FDA-approved medications, telehealth visits, and DTC lab tests are all HSA/FSA-eligible — pre-tax savings of 22-37% depending on bracket.
- Compare telehealth subscription vs cash-pay. Subscription platforms (Alloy $49-$99, Evernow $49) bundle visit + medication; for some regimens this beats à-la-carte cash-pay.
FAQ(4)
Is compounded semaglutide safe?
Safety depends entirely on the compounding pharmacy. The FDA does not test or approve compounded products. The agency has received multiple adverse-event reports tied to compounded GLP-1 — primarily dosing errors due to non-standard vial concentrations and confusion between mg and units. Buyers should verify the pharmacy is 503A or 503B-registered and licensed in their state.
Why is compounded GLP-1 cheaper than FDA-approved?
Compounding pharmacies skip the FDA approval process and do not pay branded drug premiums. Cash-pay only ($150-$400/month) vs $935-$1,349/month list for FDA-approved versions. The price gap reflects regulatory, marketing, and quality-control cost differences — not therapeutic equivalence.
Will compounded GLP-1 still be available in 2026?
Availability is narrowing. After the FDA declared semaglutide and tirzepatide shortages resolved in late 2024, the legal grounds for compounded production substantially contracted. A small number of 503B outsourcing facilities continue to compound for specific clinical scenarios (allergies, dose unavailability), but broad cash-pay compounded access has shrunk. Patients should verify current legal status with the compounding pharmacy.
Can I get insurance to cover compounded GLP-1?
No. US commercial and government insurance plans do not cover compounded GLP-1 drugs. Only FDA-approved versions (Ozempic, Wegovy, Mounjaro, Zepbound) are insurance-coverable. Compounded versions remain cash-pay only.
Common cost questions(6)
Quick answers to the most-searched pricing and coverage questions.
Frequently asked questions
- What is the average cost of Compounded Semaglutide and Tirzepatide Cost in 2026 in 2026?
- Cash-pay pricing for Compounded Semaglutide and Tirzepatide Cost in 2026 in 2026 typically ranges across pharmacy, manufacturer self-pay, telehealth, and compounded sources. See the at-a-glance pricing table above for current verified figures, ranked cheapest to priciest.
- Does insurance cover Compounded Semaglutide and Tirzepatide Cost in 2026?
- Coverage varies by carrier, plan tier, and indication. Commercial plans frequently require prior authorization; Medicare and Medicaid coverage differs by drug class and state. The coverage matrix on this page summarizes how major US insurers handle Compounded Semaglutide and Tirzepatide Cost in 2026 in 2026.
- How can I save money on Compounded Semaglutide and Tirzepatide Cost in 2026?
- Common savings paths include manufacturer coupons or self-pay programs, transparent-pricing pharmacies (Cost Plus Drugs), GoodRx cash-pay coupons, and 90-day supply orders. Review the Savings Tips block above for option-by-option comparison.
- What is the cheapest provider for Compounded Semaglutide and Tirzepatide Cost in 2026?
- Lowest-cost acquisition typically depends on insurance status. For cash-pay patients, transparent-pricing pharmacies and manufacturer self-pay programs are usually cheapest. For insured patients, in-network preferred-tier pharmacies via prior authorization are lowest. The cheapest-to-priciest table on this page ranks every option.
- Are there manufacturer coupons or patient-assistance programs for Compounded Semaglutide and Tirzepatide Cost in 2026?
- Many brand-name drugs offer manufacturer savings cards or income-based patient-assistance programs. Eligibility usually requires commercial insurance (not Medicare/Medicaid) and a valid prescription. Check the manufacturer's official website for current 2026 terms.
- How does cash-pay compare to insurance for Compounded Semaglutide and Tirzepatide Cost in 2026?
- Cash-pay is sometimes cheaper than an insurance copay — especially for generics, when deductibles are unmet, or when manufacturer self-pay programs undercut tier-3 copays. Always compare the cash price against your plan's actual out-of-pocket cost before paying through insurance.
Primary cost-data sources
Sources(4)
Authoritative references. External links open in a new tab.
Related cost guides
Zepbound Cost in 2026: Insurance Coverage, Cash Prices, and Savings
Zepbound costs $1,086/month list price without insurance in 2026. Eli Lilly's manufacturer savings card reduces commercially-insured patient cost to as low as $25/month. LillyDirec...
GLP-1 Insurance Coverage Guide 2026
Most commercial insurers cover Wegovy and Zepbound for chronic weight management in 2026 with prior authorization requiring BMI ≥30 (or ≥27 + comorbidity). Ozempic and Mounjaro are...